Tata Fund Pours up to $10 Million into Apex Kidney Care

Tata Capital Healthcare Fund II (TCHF II), the healthcare-focused private equity fund under Tata Capital, has made an investment of up to $10 million in Apex Kidney Care (AKC), securing an undisclosed equity stake. AKC, the second-largest dialysis chain in India, plans to utilize this infusion of capital to broaden its dialysis services nationwide.

India grapples with an estimated 2 million patients in Stage-5 Chronic Kidney Disease (CKD), where kidney function falls below 15%. Each year, an additional 0.2 to 0.22 million CKD-5 patients emerge. Presently, approximately 21 million dialysis sessions occur annually in India, covering only about 11% of the nation's overall yearly demand. This glaring gap stems from a mix of issues related to accessibility, affordability, and adherence.

Dr. Jatin Kothari, Co-founder and Director at Apex Kidney Care, expressed, "This new collaboration affirms the worth of our business model and our vision to provide top-tier dialysis services. The combined expertise holds the promise of unveiling numerous new opportunities to advance the business, ultimately positively impacting the lives of thousands of kidney disease patients."